Breaking news/Trending/Feature

  • Tree falls in Kwara, 2 dead, 10 injured

    Tree falls in Kwara, 2 dead, 10 injured

    0 shares
    Share 0 Tweet 0
  • Nigerian man that was beaten to death on the street in Italy

    0 shares
    Share 0 Tweet 0
  • Breaking News : STEWART EFE’S well deserved appointment as Edo State image Maker

    0 shares
    Share 0 Tweet 0
  • Biography of Edo Funk Super star- Esther .O. Edokpayi

    0 shares
    Share 0 Tweet 0
  • Sibling grabbed for attacking sister in Lagos

    0 shares
    Share 0 Tweet 0
  • The Edo State Government has debunked claims by the Indigenous People of Biafra (IPOB)

    0 shares
    Share 0 Tweet 0
  • Stephanie O. Linus appointed as National OPS-WASH Ambassador by the Honourable Minister of Water Resources

    0 shares
    Share 0 Tweet 0
  • INTERNAL SECURITY: EDO POLICE LAUNCH HOUSE-TO-HOUSE ARREST OF CULTISTS, RAID BLACKSPOTS

    0 shares
    Share 0 Tweet 0

Breaking news News

  • Tree falls in Kwara, 2 dead, 10 injured

    Tree falls in Kwara, 2 dead, 10 injured

    0 shares
    Share 0 Tweet 0
  • Nigerian man that was beaten to death on the street in Italy

    0 shares
    Share 0 Tweet 0
  • Breaking News : STEWART EFE’S well deserved appointment as Edo State image Maker

    0 shares
    Share 0 Tweet 0
  • Biography of Edo Funk Super star- Esther .O. Edokpayi

    0 shares
    Share 0 Tweet 0
  • Sibling grabbed for attacking sister in Lagos

    0 shares
    Share 0 Tweet 0
https://obalandmagazine.com/wp-content/uploads/2025/10/Edos-Fight-Against-Cult-Violence.mp4

Popular News

  • Tree falls in Kwara, 2 dead, 10 injured

    Tree falls in Kwara, 2 dead, 10 injured

    0 shares
    Share 0 Tweet 0
  • Nigerian man that was beaten to death on the street in Italy

    0 shares
    Share 0 Tweet 0
  • Breaking News : STEWART EFE’S well deserved appointment as Edo State image Maker

    0 shares
    Share 0 Tweet 0
  • Biography of Edo Funk Super star- Esther .O. Edokpayi

    0 shares
    Share 0 Tweet 0
  • Sibling grabbed for attacking sister in Lagos

    0 shares
    Share 0 Tweet 0

Subscribe to Obaland Magazine

Retail
Sunday, November 22, 2026
Login/Register
Advertise
  • Login
  • Home
  • News
  • About Us
  • Entertainment
  • Music
  • Magazine
  • Contact us
No Result
View All Result
Obaland Magazine
No Result
View All Result
Home News

US FDA Approves $40 Twice Yearly HIV Prevention Shot, Opening New Access Opportunities for 120 Countries.

Lydia EDEH by Lydia EDEH
November 2, 2026
in News
0
Tweet
Share
Share

US FDA Approves $40 Twice Yearly HIV Prevention Shot, Opening New Access Opportunities for 120 Countries.

The United States Food and Drug Administration (FDA) has granted tentative approval to a low cost generic version of lenacapavir, a groundbreaking twice-yearly injection designed to prevent HIV infection, marking a significant development in global efforts to expand access to affordable HIV prevention.

YOU MAY ALSO LIKE

Tinubu Approves ₦250m Relief for Bayelsa Boat Tragedy Victims as Death Toll Rises to 29.

Abiodun Reaffirms Ogun’s Commitment to Cultural Heritage Preservation, Tourism Development at 2026 Oronna Festival.

The approval, announced on Monday, November 2, 2026, brings the medication closer to wider distribution across 120 low- and middle income countries, particularly in regions where the cost and availability of preventive healthcare remain major challenges.

The generic injection was developed by India’s Dr. Reddy’s Laboratories in collaboration with global health organisations, including Unitaid, the Clinton Health Access Initiative (CHAI), and the Wits Reproductive Health and HIV Institute (Wits RHI).

Under an agreement established in September 2025, the generic version is expected to cost approximately $40 per person annually, making it comparable in price to existing daily oral HIV prevention medication.

Lenacapavir offers an alternative to traditional pre-exposure prophylaxis (PrEP), which generally requires individuals to take preventive medication every day. The injectable version is administered twice annually, potentially improving adherence among people who find daily medication difficult to maintain.

Clinical studies have demonstrated exceptionally high effectiveness, with the injection recording near total protection against HIV infection among participants in major prevention trials.

The development is particularly significant for Africa, where expanding access to effective HIV prevention remains an important public health priority. The continent continues to carry a substantial proportion of the global HIV burden, making affordable and convenient prevention options essential to reducing new infections.

According to the organisations supporting the initiative, initial supplies of the generic medication are expected to reach some countries before the end of 2026, while broader distribution is anticipated in 2027.

However, the FDA’s decision represents tentative approval rather than unrestricted commercial authorisation in the United States. The designation confirms that the generic product meets the agency’s required standards but allows access through applicable international procurement arrangements while the original branded product remains protected by patent restrictions.

The branded version, marketed by Gilead Sciences as Yeztugo, has a reported US list price of approximately $28,218 annually. Generic sales within the United States remain restricted by existing patent protections.

Gilead previously entered voluntary licensing agreements with six generic manufacturers to support the production and distribution of affordable lenacapavir across 120 eligible countries in Africa, Asia and Latin America.

Despite the promising development, public health experts have cautioned that regulatory approval and affordable pricing alone will not guarantee widespread access. Governments will still need to secure funding, complete national regulatory processes, strengthen healthcare delivery systems and ensure adequate supplies.

Medical professionals have also emphasized the importance of HIV testing before treatment begins and before subsequent injections. Administering lenacapavir to someone with an undiagnosed HIV infection can increase the risk of developing drug resistant HIV.

For African countries, including Nigeria, the development presents an opportunity to strengthen existing HIV prevention programmes and widen access to long acting preventive medication. However, the timing of availability will depend on national regulatory approvals, procurement arrangements and distribution plans.

The approval represents an important step towards making advanced HIV prevention more accessible beyond wealthier economies. Whether it translates into meaningful reductions in new infections will ultimately depend on how effectively governments and international partners convert the scientific breakthrough into affordable, reliable and equitable healthcare access.

Tweet
Share
Share
Tags: Affordable HealthcareFDA Drug ApprovalHIV PreventionHIV Prevention in AfricaLenacapavir injection

Related Posts

Tinubu Unveils ₦400bn Student Housing Initiative, Targets 50,000 Hostel Beds Across Federal Institutions by 2027.
News

Tinubu Approves ₦250m Relief for Bayelsa Boat Tragedy Victims as Death Toll Rises to 29.

November 22, 2026
Abiodun Reaffirms Ogun’s Commitment to Cultural Heritage Preservation, Tourism Development at 2026 Oronna Festival.
News

Abiodun Reaffirms Ogun’s Commitment to Cultural Heritage Preservation, Tourism Development at 2026 Oronna Festival.

November 22, 2026
Reps Committee Raises Alarm Over Alleged Constitutional Violations in Federal University Recruitment
News

Reps Committee Raises Alarm Over Alleged Constitutional Violations in Federal University Recruitment

November 22, 2026
Tinubu Celebrates NASFAT President Abdulrauf on Birthday, Commends Contributions to Islam and National Development
News

Tinubu Celebrates NASFAT President Abdulrauf on Birthday, Commends Contributions to Islam and National Development

November 22, 2026
UNICEF Raises Alarm as 624,000 Children Remain Out of School in Sokoto, Kebbi and Zamfara.
News

UNICEF Urges Bauchi Government to Prioritise Children’s Voices, Education and Healthcare.

November 22, 2026
TRCN Detects 50 Suspected Exam Impersonators as Nigeria Tightens Teacher Professionalization Drive.
News

TRCN Detects 50 Suspected Exam Impersonators as Nigeria Tightens Teacher Professionalization Drive.

November 22, 2026

Search

No Result
View All Result

Recent Posts

  • Tinubu Approves ₦250m Relief for Bayelsa Boat Tragedy Victims as Death Toll Rises to 29. November 22, 2026
  • Abiodun Reaffirms Ogun’s Commitment to Cultural Heritage Preservation, Tourism Development at 2026 Oronna Festival. November 22, 2026
  • Reps Committee Raises Alarm Over Alleged Constitutional Violations in Federal University Recruitment November 22, 2026
  • Tinubu Celebrates NASFAT President Abdulrauf on Birthday, Commends Contributions to Islam and National Development November 22, 2026
  • UNICEF Urges Bauchi Government to Prioritise Children’s Voices, Education and Healthcare. November 22, 2026
  • TRCN Detects 50 Suspected Exam Impersonators as Nigeria Tightens Teacher Professionalization Drive. November 22, 2026
  • WAEC, NECO Registration: TRCN Gives Nigerian Schools December 2026 Deadline to Certify 75% of Teachers. November 22, 2026
  • Tinubu Unveils ₦400bn Student Housing Initiative, Targets 50,000 Hostel Beds Across Federal Institutions by 2027. November 22, 2026
  • Terrorists Kill Niger Village Head, Five Others, Abduct Residents in Fresh Attack November 22, 2026
  • Abiodun Condemns Attack on Football Legend Segun Odegbami, Demands Arrest of Suspects November 22, 2026

Categories

  • Community (7)
  • CRIME NEWS (1)
  • culture (8)
  • Education (6)
  • Electrical (17)
  • Entertainment (496)
  • fashion (13)
  • Feature (33)
  • Gist (25)
  • Gossip (36)
  • Government (381)
  • Headlines (1)
  • health (83)
  • history (13)
  • International (30)
  • INTERVIEW (9)
  • music (47)
  • Nature (5)
  • news (2,007)
  • News (5,803)
  • Non profit (19)
  • PHOTO (4)
  • Political (305)
  • press release (32)
  • Property (14)
  • review (21)
  • Science (9)
  • Sport (48)
  • Sports (322)
  • TECHNOLOGY (14)
  • Video (4)
  • world (105)

About

About Obaland Magazine

Obaland Magazine is Nigeria’s trusted source for entertainment, political, and social news. We connect readers with verified stories that matter.

Contact Us

obaland podcast radio

Obaland Podcast

Listen to engaging talk shows and interviews from Obaland Multichoice Media House.

🎧 Listen Now

Support us Today

Support Us

Your donations help us maintain free and independent journalism.

Donate Now
No Result
View All Result
  • Login
  • Home
  • News
  • About Us
  • Entertainment
  • Music
  • Magazine
  • Contact us

All right reserved© 2023 Obaland magazine

1
WhatsApp
Hello 👋
Can we help you?
Open chat